Daniel E Katzman

Title: The Innovations of Daniel E Katzman

Introduction

Daniel E Katzman is a notable inventor based in Newton, MA (US). He has made significant contributions to the field of neurological treatments, holding 2 patents that focus on innovative methods for addressing impaired neurological functions.

Latest Patents

Katzman's latest patents include groundbreaking work on high potency dopaminergic treatments for neurological impairment associated with brain injury. One patent describes methods and compositions for treating impaired neurological function, including altered state of consciousness disorders, by administering apomorphine to individuals who have sustained brain injuries. Another patent outlines the administration of at least 1000 mg or more of L-dopa (levodopa) per day to stimulate recovery from altered consciousness states, such as comas. Additionally, he has developed a modafinil-based treatment for premature ejaculation, which involves methods and compositions comprising modafinil for male individuals.

Career Highlights

Katzman is associated with Neurohealing Pharmaceuticals, Inc., where he continues to advance his research and innovations in the field of neurology. His work is pivotal in developing effective treatments for conditions that significantly impact patients' quality of life.

Collaborations

Katzman collaborates with esteemed colleagues, including Elkan R Gamzu and Neal M Farber, who contribute to the research and development efforts at Neurohealing Pharmaceuticals, Inc.

Conclusion

Daniel E Katzman is a prominent inventor whose work in neurological treatments is paving the way for innovative therapies. His contributions are vital in enhancing the understanding and treatment of neurological impairments.